granulocyte-macrophage colony-stimulating factor
1 abstract
Abstract
Patterns of improvement following initial response in patients treated with naxitamab for relapsed/refractory high-risk neuroblastoma.Org: Pediatric Cancer Center Barcelona, Hospital Sant Joan de Deu, Queen Mary Hospital and Hong Kong Children's Hospital, IRCCS Istituto Giannina Gaslini, Center for Pediatric and Adolescent Medicine,